Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4170361000168116 | cerliponase alfa 150 mg / 5 mL injection, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4170371000168110 | cerliponase alfa 150 mg/5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cerliponase alfa 150 mg/5 mL injection, vial | Is a | cerliponase alfa | true | Inferred relationship | Some | ||
| cerliponase alfa 150 mg/5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| cerliponase alfa 150 mg/5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| cerliponase alfa 150 mg/5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1831085017 | |
| cerliponase alfa 150 mg/5 mL injection, vial | has intended active ingredient | cerliponase alfa | true | Inferred relationship | Some | 1831085016 | |
| cerliponase alfa 150 mg/5 mL injection, vial | has Australian BoSS | cerliponase alfa | true | Inferred relationship | Some | 1831085016 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| cerliponase alfa 150 mg/5 mL injection [2 x 5 mL vials] (&) inert substance solution [5 mL vial], 1 pack | has MPUU | True | cerliponase alfa 150 mg/5 mL injection, vial | Inferred relationship | Some | 2 |
| Brineura (cerliponase alfa 150 mg/5 mL) injection, 5 mL vial | Is a | True | cerliponase alfa 150 mg/5 mL injection, vial | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR